Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors
Clinical trial NCT01803282 · COMPLETED
Trial details
- NCT number
- NCT01803282
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-29
- Primary completion
- 2019-04-23
- Enrollment
- 236
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.